Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis

• Nadege Nziza,
• Deniz Cizmeci,
• Leela Davies,
• Leela Davies,
• Edward B. Irvine,
• Edward B. Irvine,
• Wonyeong Jung,
• Brooke A. Fenderson,
• Marwou de Kock,
• Willem A. Hanekom,
• Willem A. Hanekom,
• Kees L. M. C. Franken,
• Cheryl L. Day,
• Tom H. M. Ottenhoff,
• Galit Alter

Affiliations

Nadege Nziza

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Deniz Cizmeci

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Leela Davies

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Leela Davies

Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, United States

Edward B. Irvine

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Edward B. Irvine

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States

Wonyeong Jung

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Brooke A. Fenderson

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States

Marwou de Kock

South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Willem A. Hanekom

Africa Health Research Institute, Durban, South Africa

Willem A. Hanekom

Division of Infection and Immunity, University College London, London, United Kingdom

Kees L. M. C. Franken

Department of Infectious Disease, Leiden University, Leiden, Netherlands

Cheryl L. Day

Department of Microbiology and Immunology, Emory University School of Medicine, Emory University, Atlanta, GA, United States

Tom H. M. Ottenhoff

Department of Infectious Disease, Leiden University, Leiden, Netherlands

Galit Alter

Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States